13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001214659-23-015129
Total Value
$650.9M
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 3,130,000 | $119.1M | 18.29% |
| 2 | ROIVANT SCIENCES LTD | ROIV | 4,367,000 | $51.0M | 7.84% |
| 3 | CYMABAY THERAPEUTICS INC | 23257D103 | 3,073,750 | $45.8M | 7.04% |
| 4 | VERONA PHARMA PLC | 925050106 | 2,369,000 | $38.6M | 5.93% |
| 5 | IMMUNOVANT INC | IMVT | 1,000,000 | $38.4M | 5.90% |
| 6 | ARCUS BIOSCIENCES INC | RCUS | 1,968,000 | $35.3M | 5.43% |
| 7 | INSMED INC | INSM | 1,284,000 | $32.4M | 4.98% |
| 8 | MIRATI THERAPEUTICS INC | 60468T105 | 655,051 | $28.5M | 4.38% |
| 9 | APELLIS PHARMACEUTICALS INC | APLS | 675,000 | $25.7M | 3.94% |
| 10 | BRIDGEBIO PHARMA INC | BBIO | 971,639 | $25.6M | 3.94% |
| 11 | CELLDEX THERAPEUTICS INC NEW | CLDX | 759,898 | $20.9M | 3.21% |
| 12 | 89BIO INC | 282559103 | 1,219,157 | $18.8M | 2.89% |
| 13 | RENEO PHARMACEUTICALS INC | 75974E103 | 2,279,870 | $17.4M | 2.67% |
| 14 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,067,143 | $16.4M | 2.51% |
| 15 | APELLIS PHARMACEUTICALS INC | APLS | 400,000 | $15.2M | 2.34% |
| 16 | AN2 THERAPEUTICS INC | ANTX | 867,575 | $14.0M | 2.14% |
| 17 | AMYLYX PHARMACEUTICALS INC | AMLX | 695,000 | $12.7M | 1.96% |
| 18 | TAYSHA GENE THERAPIES INC | TSHA | 2,777,778 | $8.8M | 1.35% |
| 19 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 750,000 | $8.6M | 1.32% |
| 20 | GOSSAMER BIO INC | GOSS | 8,187,883 | $6.8M | 1.05% |
| 21 | AEROVATE THERAPEUTICS INC | 008064107 | 497,370 | $6.7M | 1.04% |
| 22 | DIANTHUS THERAPEUTICS INC | DNTH | 480,000 | $6.6M | 1.01% |
| 23 | DYNE THERAPEUTICS INC | DYN | 692,945 | $6.2M | 0.95% |
| 24 | PMV PHARMACEUTICALS INC | PMVP | 904,000 | $5.6M | 0.85% |
| 25 | INOZYME PHARMA INC | 45790W108 | 1,300,000 | $5.5M | 0.84% |
| 26 | XILIO THERAPEUTICS INC | XLO | 2,318,500 | $4.9M | 0.75% |
| 27 | ANNEXON INC | ANNX | 2,050,000 | $4.8M | 0.74% |
| 28 | GLYCOMIMETICS INC | 38000Q102 | 3,000,000 | $4.5M | 0.69% |
| 29 | VIKING THERAPEUTICS INC | VKTX | 375,000 | $4.2M | 0.64% |
| 30 | MONTE ROSA THERAPEUTICS INC | GLUE | 812,895 | $3.9M | 0.60% |
| 31 | JASPER THERAPEUTICS INC | JSPRW | 4,468,114 | $3.1M | 0.48% |
| 32 | CENTESSA PHARMACEUTICALS PLC | CNTA | 475,600 | $3.1M | 0.47% |
| 33 | VIR BIOTECHNOLOGY INC | VIR | 325,050 | $3.0M | 0.47% |
| 34 | TRAVERE THERAPEUTICS INC | TVTX | 300,000 | $2.7M | 0.41% |
| 35 | LEXICON PHARMACEUTICALS INC | LXRX | 1,923,076 | $2.1M | 0.32% |
| 36 | ORIC PHARMACEUTICALS INC | ORIC | 204,500 | $1.2M | 0.19% |
| 37 | ITEOS THERAPEUTICS INC | 46565G104 | 102,000 | $1.1M | 0.17% |
| 38 | CYMABAY THERAPEUTICS INC | 23257D103 | 60,000 | $894,600 | 0.14% |
| 39 | BIONOMICS LIMITED | 09063M205 | 168,000 | $453,600 | 0.07% |
| 40 | HEPION PHARMACEUTICALS INC | CTRVP | 67,500 | $336,825 | 0.05% |